Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06767514
A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression (HARMONi-7)
Status
Open
Conditions
Lung
Phases
3 (Cancer Control)
Age Group
Adult
Main Investiagtor
Vu, John
Practice
Lung
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT06767514
Secondary Trial ID Number
SMT112-3007
Keywords
Treatment